Reversal of Inflammatory and Noninflammatory Visceral Pain by Central or Peripheral Actions of Sumatriptan

Gastroenterology

Volumn 135, Issue 4, 2008, Pages 1369-1378

  Vera Portocarrero, Louis P ^a   Ossipov, Michael H ^a   King, Tamara ^a   Porreca, Frank ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; DIBUTYLTIN DICHLORIDE; SEROTONIN 1B ANTAGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 1D ANTAGONIST; SEROTONIN 1D RECEPTOR; SUMATRIPTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; DOSE TIME EFFECT RELATION; DRUG DOSE COMPARISON; DRUG RECEPTOR BINDING; HYPERSENSITIVITY; INFLAMMATION; IRRITABLE COLON; MALE; NONHUMAN; PANCREATITIS; PRIORITY JOURNAL; RAT; ROSTRAL VENTROMEDIAL MEDULLA; TREATMENT RESPONSE; VISCERAL PAIN;

EID: 53049104302     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.06.085     Document Type: Article

References (50)

1. Gebhart G.F. Peripheral contributions to visceral hyperalgesia. Can J Gastroenterol 13 Suppl A (1999) A37-A41
2. Cherny N., Ripamonti C., Pereira J., et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 19 (2001) 2542-2554
3. Ballantyne J.C., and LaForge K.S. Opioid dependence and addiction during opioid treatment of chronic pain. Pain 129 (2007) 235-255
4. Cady R., and Schreiber C. Sumatriptan: update and review. Expert Opin Pharmacother 7 (2006) 1503-1514
5. Castro M.E., Pascual J., Romon T., et al. Differential distribution of [3H]sumatriptan binding sites (5-HT1B, 5-HT1D, and 5-HT1F receptors) in human brain: focus on brainstem and spinal cord. Neuropharmacology 36 (1997) 535-542
6. Pierce P.A., Xie G.X., Levine J.D., et al. 5-Hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: a polymerase chain reaction study. Neuroscience 70 (1996) 553-559
7. Moro E., Crema F., De P.F., et al. Triptans and gastric accommodation: pharmacological and therapeutic aspects. Dig Liver Dis 36 (2004) 85-92
8. Tack J., Coulie B., Wilmer A., et al. Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man. Gut 46 (2000) 468-473
9. Mulak A., and Paradowski L. Effect of 5-HT1 agonist (sumatriptan) on anorectal function in irritable bowel syndrome patients. World J Gastroenterol 12 (2006) 1591-1596
10. Vera-Portocarrero L.P., Lu Y., and Westlund K.N. Nociception in persistent pancreatitis in rats: effects of morphine and neuropeptide alterations. Anesthesiology 98 (2003) 474-484
11. Buscher H.C., Wilder-Smith O.H., and van G.H. Chronic pancreatitis patients show hyperalgesia of central origin: a pilot study. Eur J Pain 10 (2006) 363-370
12. Winston J.H., Toma H., Shenoy M., et al. Acute pancreatitis results in referred mechanical hypersensitivity and neuropeptide up-regulation that can be suppressed by the protein kinase inhibitor k252a. J Pain 4 (2003) 329-337
13. Wick E.C., Hoge S.G., Grahn S.W., et al. Transient receptor potential vanilloid 1, calcitonin gene-related peptide, and substance P mediate nociception in acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 290 (2006) G959-G969
14. Dimcevski G., Staahl C., Andersen S.D., et al. Assessment of experimental pain from skin, muscle, and esophagus in patients with chronic pancreatitis. Pancreas 35 (2007) 22-29
15. Dimcevski G., Sami S.A., Funch-Jensen P., et al. Pain in chronic pancreatitis: the role of reorganization in the central nervous system. Gastroenterology 132 (2007) 1546-1556
16. Bourdu S., Dapoigny M., Chapuy E., et al. Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats. Gastroenterology 128 (2005) 1996-2008
17. Verne G.N., Robinson M.E., and Price D.D. Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome. Pain 93 (2001) 7-14
18. Azpiroz F., Bouin M., Camilleri M., et al. Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil 19 (2007) 62-88
19. Humphrey P.P., and Goadsby P.J. The mode of action of sumatriptan is vascular?. A debate. Cephalalgia 14 (1994) 401-410
20. Ahn A.H., and Basbaum A.I. Where do triptans act in the treatment of migraine?. Pain 115 (2005) 1-4
21. Zhuo M., Sengupta J.N., and Gebhart G.F. Biphasic modulation of spinal visceral nociceptive transmission from the rostroventral medial medulla in the rat. J Neurophysiol 87 (2002) 2225-2236
22. Zhuo M., and Gebhart G.F. Facilitation and attenuation of a visceral nociceptive reflex from the rostroventral medulla in the rat. Gastroenterology 122 (2002) 1007-1019
23. Vera-Portocarrero L.P., Xie J.Y., Kowal J., et al. Descending facilitation from the rostral ventromedial medulla maintains visceral pain in rats with experimental pancreatitis. Gastroenterology 130 (2006) 2155-2164
24. Sparmann G., Merkord J., Jaschke A., et al. Pancreatic fibrosis in experimental pancreatitis induced by dibutyltin dichloride. Gastroenterology 112 (1997) 1664-1672
25. Kayser V., Aubel B., Hamon M., et al. The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain. Br J Pharmacol 137 (2002) 1287-1297
26. Renyi L., Larsson L.G., Berg S., et al. Biochemical and behavioural effects of isamoltane, a β-adrenoceptor antagonist with affinity for the 5-HT1B receptor of rat brain. Naunyn Schmiedebergs Arch Pharmacol 343 (1991) 1-6
27. Price G.W., Burton M.J., Collin L.J., et al. SB-216641 and BRL-15572: compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors. Naunyn Schmiedebergs Arch Pharmacol 356 (1997) 312-320
28. Ottani A., Ferraris E., Giuliani D., et al. Effect of sumatriptan in different models of pain in rats. Eur J Pharmacol 497 (2004) 181-186
29. Burgess S.E., Gardell L.R., Ossipov M.H., et al. Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain. J Neurosci 22 (2002) 5129-5136
30. Giamberardino M.A. Referred muscle pain/hyperalgesia and central sensitisation. J Rehabil Med (2003) 85-88
31. Al-Chaer E.D., Kawasaki M., and Pasricha P.J. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology 119 (2000) 1276-1285
32. Vera-Portocarrero L.P., and Westlund K.N. Attenuation of nociception in a model of acute pancreatitis by an NK-1 antagonist. Pharmacol Biochem Behav 77 (2004) 631-640
33. Feniuk W., Humphrey P.P., Perren M.J., et al. Rationale for the use of 5-HT1-like agonists in the treatment of migraine. J Neurol 238 Suppl 1 (1991) S57-S61
34. Potrebic S., Ahn A.H., Skinner K., et al. Peptidergic nociceptors of both trigeminal and dorsal root ganglia express serotonin 1D receptors: implications for the selective antimigraine action of triptans. J Neurosci 23 (2003) 10988-10997
35. Chen J.J., Vasko M.R., Wu X., et al. Multiple subtypes of serotonin receptors are expressed in rat sensory neurons in culture. J Pharmacol Exp Ther 287 (1998) 1119-1127
36. Ahn A.H., and Basbaum A.I. Tissue injury regulates serotonin 1D receptor expression: implications for the control of migraine and inflammatory pain. J Neurosci 26 (2006) 8332-8338
37. De P.F., and Tonini M. Irritable bowel syndrome: new agents targeting serotonin receptor subtypes. Drugs 61 (2001) 317-332
38. Bornman P.C., Marks I.N., Girdwood A.W., et al. Pathogenesis of pain in chronic pancreatitis: ongoing enigma. World J Surg 27 (2003) 1175-1182
39. Jennings E.A., Ryan R.M., and Christie M.J. Effects of sumatriptan on rat medullary dorsal horn neurons. Pain 111 (2004) 30-37
40. Levy D., Jakubowski M., and Burstein R. Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B/1D receptor agonists. Proc Natl Acad Sci U S A 101 (2004) 4274-4279
41. Bruinvels A.T., Landwehrmeyer B., Gustafson E.L., et al. Localization of 5-HT1B, 5-HT1D α, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain. Neuropharmacology 33 (1994) 367-386
42. Nicholas A.P., Pieribone V.A., and Hokfelt T. Cellular localization of messenger RNA for β-1 and β-2 adrenergic receptors in rat brain: an in situ hybridization study. Neuroscience 56 (1993) 1023-1039
43. Li Y.W., Guyenet P.G., and Bayliss D.A. Voltage-dependent calcium currents in bulbospinal neurons of neonatal rat rostral ventrolateral medulla: modulation by α2-adrenergic receptors. J Neurophysiol 79 (1998) 583-594
44. Sheftell F.D., Bigal M.E., Tepper S.J., et al. Sumatriptan: a decade of use and experience in the treatment of migraine. Expert Rev Neurother 4 (2004) 199-209
45. Ekbom K. Treatment of cluster headache: clinical trials, design and results. Cephalalgia 15 Suppl 15 (1995) 33-36
46. Bingham S., Davey P.T., Sammons M., et al. Inhibition of inflammation-induced thermal hypersensitivity by sumatriptan through activation of 5-HT(1B/1D) receptors. Exp Neurol 167 (2001) 65-73
47. Zochodne D.W., and Ho L.T. Sumatriptan blocks neurogenic inflammation in the peripheral nerve trunk. Neurology 44 (1994) 161-163
48. Arvieu L., Mauborgne A., Bourgoin S., et al. Sumatriptan inhibits the release of CGRP and substance P from the rat spinal cord. Neuroreport 7 (1996) 1973-1976
49. Ghelardini C., Galeotti N., Nicolodi M., et al. Involvement of central cholinergic system in antinociception induced by sumatriptan in mouse. Int J Clin Pharmacol Res 17 (1997) 105-109
50. Jain N.K., and Kulkarni S.K. Antinociceptive effect of sumatriptan in mice. Indian J Exp Biol 36 (1998) 973-979